For facial use, limit it to 2 minutes
Radkhah H, Rahimipour Anaraki S, Parhizkar Roudsari P, Arabzadeh Bahri R, Zooravar D, Asgarian S, et al
Its novel mechanism allows the peptide to act as an agonist for both GLP-1 and GIP receptors
Cardiometabolic Burden in Serious Mental Illness Schizophrenia, major depressive disorder, bipolar disorder (BD), and other SMIs are severe, prevalent, and lifelong conditions that are major contributors to disability, reduced healthspan, and diminished social and economic participation, particularly in younger populations
[4] Understanding how each agent works is essential before considering their combined use
That's why people love it so much